Cumberland Emerging Technologies, Inc. (CET) announced this week that Belmont University has established the Belmont School of Pharmacy Department of Pharmaceutical Sciences Laboratory at the CET Life Sciences Center. The Life Sciences Center, which is located in downtown Nashville, provides lab and office space, equipment and infrastructure to early-stage biopharmaceutical ventures.
Belmont has leased the space to support research and service programs of its School of Pharmacy. The primary objective of the lab is to provide dosage form development, characterization and quality analysis. The school will work with the pharmaceutical industry and local and regional health care providers to meet previously unmet and arising needs related to drug delivery.
“The work being performed at the Life Sciences Center is designed to help provide drug delivery solutions, which is unique to pharmacy practice and which, until now, has not played a major role in middle Tennessee’s robust health care scene,” said Dr. Andrew Webster (pictured above), chair and professor of pharmaceutical sciences at Belmont’s School of Pharmacy. “By partnering with CET, our faculty and students have access to a community of resources to help advance research that will help drug developers bring their products to patients who need them most.”
“We are delighted to welcome Belmont School of Pharmacy to our growing roster of tenants at the Life Sciences Center,” said A.J. Kazimi, chief executive officer of Cumberland Pharmaceuticals and CET. “Partnering with outstanding academic research and training programs like this one is a key component of CET’s strategy, and we look forward to providing laboratory and equipment infrastructure to support their promising research.”
Belmont’s School of Pharmacy announced last week that it has received approval from The Accreditation Council for Pharmacy Education (ACPE) to seat its first class of 75 students for the 2008-09 academic year.
Cumberland Emerging Technologies, Inc. (www.cet-fund.com) is a joint initiative between Cumberland Pharmaceuticals Inc., Vanderbilt University and the Tennessee Technology Development Corporation. The mission of CET is to bring biomedical technologies and products conceived at Vanderbilt and other regional research centers to the marketplace. CET helps manage the development and commercialization process for select projects, and provides expertise on intellectual property, regulatory, manufacturing and marketing issues that are critical to successful new biomedical products. CET’s Life Sciences Center, located in Nashville, Tennessee, provides laboratory space, equipment and infrastructure to early-stage life sciences companies.
